ZYN & Siberia Nicotine Pouch Recall — No Market Authorization 2026

Health Canada has issued a recall for two brands of nicotine pouches — ZYN and Siberia — after it was determined that these products were being sold in Canada without the required market authorization (Drug Identification Number, or DIN). The recall, identified under file number RA-82193, was issued on June 10, 2026, and affects all lot numbers of both brands currently distributed at the retail level across Canada.

What Products Are Being Recalled?

The recall covers the following specific nicotine pouch products sold under two separate brands:

• Siberia Nicotine Pouches 35 mg — Available in flavors including ‘Super Slim,’ ‘White Dry,’ ‘Power White,’ and ‘White Slim.’ Dosage form: Pouch. Strength: Nicotine 35 mg. All lot numbers affected.
• ZYN Nicotine Pouches 6 mg — Available in flavors including ‘Cool Mint,’ ‘Wintergreen,’ ‘Spearmint,’ ‘Menthol,’ ‘Chill,’ and ‘Peppermint.’ Dosage form: Pouch. Strength: Nicotine 6 mg. All lot numbers affected.

Both products were distributed by Smoke Arsenal, located at 290 Carlingview Drive, Etobicoke, Ontario M9W 5G1, Canada. The depth of this recall extends to retailers.

Why Was This Recall Issued?

The core issue is that both the ZYN and Siberia nicotine pouches were sold in Canada without a valid market authorization, meaning they do not hold a Drug Identification Number (DIN) as required by Canadian law for health products. Health Canada classifies this recall as a Type II recall under the category of Health Products — Drugs. Selling unauthorized health products is a serious regulatory violation, as there is no assurance that these products have undergone the required safety, efficacy, and quality reviews mandated by Health Canada.

Who Is Affected?

This recall is directed at the general public, healthcare providers, and industry stakeholders across Canada. Anyone who has purchased ZYN 6 mg nicotine pouches or Siberia 35 mg nicotine pouches — regardless of flavor or lot number — may be in possession of an affected product. Since all lot numbers are included in the recall, no batch of these products has been deemed safe or compliant for sale in Canada.

Consumers who use nicotine pouches for smoking cessation or nicotine replacement therapy should be especially cautious, as these unauthorized products have not been evaluated for safety or effectiveness by a Canadian regulatory authority.

What Should You Do?

• Check whether you have any ZYN 6 mg or Siberia 35 mg nicotine pouches at home or currently in use.
• Do not abruptly discontinue use without first consulting your healthcare provider, especially if you rely on these products for nicotine replacement.
• Contact the recalling firm, Smoke Arsenal, at 290 Carlingview Drive, Etobicoke, Ontario M9W 5G1, Canada, if you have any questions or concerns about the recall.
• Report any health product-related side effects or adverse reactions to Health Canada through the MedEffect Canada adverse reaction reporting system.
• Report any additional health product safety complaints to Health Canada using their official complaints portal.

Official Statement

Health Canada has stated that the issue is a product sold without market authorization (DIN) in Canada. The department urges affected consumers to consult a healthcare professional if they have any health concerns related to the use of these products. Health Canada continues to monitor the marketplace and take action against unauthorized health products to protect the safety and well-being of Canadians. Consumers are also encouraged to subscribe to Health Canada recall notifications to stay informed of future safety alerts.